Skip to main content
SpringerLink
Log in

In vitro kinetics of styrene and styrene oxide metabolism in rat, mouse, and human

  • Original Investigations
  • Published:
Archives of Toxicology Aims and scope Submit manuscript

Abstract

Styrene oxide (SO), a labile metabolite of styrene, is generally accepted as being responsible for any genotoxicity associated with styrene. To better define the hazard associated with styrene, the activity of the enzymes involved in the formation (monooxygenase) and destruction of SO (epoxide hydrolase and glutathione-S-transferase) were measured in the liver and lungs from naive and styrene-exposed male Sprague-Dawley rats and B6C3F1 mice (three daily 6-h inhalation exposures at up to 600 ppm styrene) and Fischer 344 rats (four daily 6-h inhalation exposures at up to 1000 ppm styrene), and in samples of human liver tissue. Additionally, the time course of styrene and SO in the blood was measured following oral administration of 500 mg styrene/kg body weight to naive Fischer rats and rats previously exposed to 1000 ppm styrene. The affinity of hepatic monooxygenase for styrene, as measured by the Michaelis constant (K m), was similar in the rat, mouse, and human. Based on theV max for monooxygenase activity and the relative liver and body size, the mouse had the greatest capacity and humans the lowest capacity to form SO from styrene. In contrast, human epoxide hydrolase had a greater affinity (i. e., lowerK m) for SO than epoxide hydrolase from rats or mice while the apparent Vmax for epoxide hydrolase was similar in the rat, mouse, and human liver. However, the activity of epoxide hydrolase relative to monooxygenase activity was much greater in the human than in the rodent liver. Hepatic glutathione-S-transferase activity, as indicated by theV max, was 6- to 33-fold higher than epoxide hydrolase activity. However, the significance of the high glutathione-S-transferase activity is unknown because hydrolysis, rather than conjugation, is the primary pathway for SO detoxification in vivo. Human hepatic glutathione-S-transferase activity was extremely variable between individual human livers and much lower than in rat or mouse liver. Prior exposure to styrene had no effect on monooxygenase activity or on blood styrene levels in rats given a large oral dose of styrene. In contrast, prior exposure to styrene increased hepatic epoxide hydrolase activity 1.6-fold and resulted in lower (0.1>P>0.05) blood SO levels in rats given a large oral dose of styrene. Qualitatively, these data indicate that the mouse has the greatest capacity and the human the lowest capacity to form SO. In addition, human liver should be more effective than rodent liver in hydrolyzing low levels of SO. Quantitative evaluation of the species differences in enzyme levels are being evaluated with the development of a physiologically based pharmacokinetic model for styrene that includes SO.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Andersen ME (1987) Tissue dosimetry in risk assessment, or what's the problem here anyway. In: Pharmacokinetics in risk assessment, drinking water and health, vol. 8. National Academy, Washington, pp 8–23

    Google Scholar 

  • Andersen ME, Gargas ML, Ramsey JC (1984) Inhalation pharmacokinetics: evaluating systemic extraction, total in vivo metabolism, and the time-course of enzyme induction for inhaled styrene in rats based on arterial blood: inhaled air concentration ratios. Toxicol Appl Pharmacol 73: 176–187

    PubMed  Google Scholar 

  • Barale R (1991) The genetic toxicology of styrene and styrene oxide. Mutat Res 257: 107–126

    PubMed  Google Scholar 

  • Bard Y (1974) Nonlinear parameter estimation. Academic, Orlando

    Google Scholar 

  • Beaune P, Kremers PG, Kaminsky LW, DeGraeve J, Guengerich FP (1986) Comparison of monooxygenase activities and cytochrome P-450 isozyme concentrations in human liver microsomes. Drug Metab Dispos 14: 437–442

    PubMed  Google Scholar 

  • Belvedere G, Pachecka J, Cantoni L, Mussini E, Salmona M (1976) A specific gas Chromatographic method for the determination of microsomal styrene monooxygenase and styrene epoxide hydratase activities. J Chromatogr 118: 387–393

    PubMed  Google Scholar 

  • Belvedere G, Cantoni L, Facchinetti T, Salmona M (1977) Kinetic behavior of microsomal styrene monooxygenase and styrene epoxide hydratase in different animal species. Experentia 33: 708–709

    Google Scholar 

  • Bocker RH, Guengerich FP (1986) Oxidation of 4-aryl- and 4-alkyl-substituted 2,6-dimethyl-3,5-bis(alkoxycarbonyl)-1,4-dihydropyridines by human liver microsomes and immunochemical evidence for the involvement of a form of cytochrome P-450. J Med Chem 29: 1596–1603

    PubMed  Google Scholar 

  • Bond JA (1989) Review of the toxicology of styrene. Critical Rev Toxicol 19: 227–249

    Google Scholar 

  • Cantoni L, Salmona M, Facchinetti T, Pantarotto C, Belvedere G (1978) Hepatic and extrahepatic formation and hydration of styrene oxide in vitro in animals of different species and sex. Toxicol Lett 2: 179–186

    Google Scholar 

  • Caulcutt R, Boddy R (1983) Statistics for analytical chemists. Chapman and Hall, New York

    Google Scholar 

  • Corley RA, Mendrala AL, Smith FA, Staats DA, Gargas ML, Conolly RB, Andersen ME, Reitz RH (1990) Development of a physiologically-based pharmacokinetic model for chloroform. Toxicol Appl Pharmacol 103: 512–527

    PubMed  Google Scholar 

  • Das M, Dixit R, Mushtaq M, Srivastava SP, Seth PK (1981) Effects of styrene on mixed-function oxidase enzymes, glutathione content and glutathione-S-transferase activity in rats. Drug Chem Toxicol 4: 219–227

    PubMed  Google Scholar 

  • Ehrenberg L, Hiesche KD, Osterman-Golkar S, Wennberg I (1974) Evaluation of genetic risks of alkylating agents: tissue doses in the mouse from air contaminated with ethylene oxide. Mutat Res 24, 83–103

    PubMed  Google Scholar 

  • Elovaara E, Vainio H, Aitio A (1990) Pulmonary toxicity of inhaled styrene in acetone-, phenobarbital- and 3-methylcholanthrene-treated rats. Arch Toxicol 64: 365–369

    PubMed  Google Scholar 

  • Gibaldi M, Perrier D (1975) Pharmacokinetics. Dekker, New York

    Google Scholar 

  • Guengerich FP (1977) Studies on the activation of a model furan compound -Toxicity and covalent binding of 2-(N-ethylcarbamoylhydroxymethyl) furan. Biochem Pharmacol 26: 1901–1915

    PubMed  Google Scholar 

  • Guengerich FP, Martin MV, Beaune PH, Kremers P, Wolff T, Waxman DJ (1986 a). Characterization of rat and human liver microsomal cytochrome P-450 forms involved in nifedipine oxidation, a prototype for genetic polymorphism in oxidative drug metabolism. J Biol Chem 261: 5051–5060

    PubMed  Google Scholar 

  • Guengerich FP, Muller-Enoch D, Blair IA (1986 b). Oxidation of quinidine by human liver cytochrome P-450. Mol Pharmacol 30: 287–295

    PubMed  Google Scholar 

  • Hall SD, Guengerich FP, Branch RA, Wilkinson GR (1987) Characterization and inhibition of mephenytoin 4-hydroxylase in human liver cytochrome P-450. J Pharmacol Exp Ther 240: 216–222

    PubMed  Google Scholar 

  • Harms PG, Ojeda SR (1974) A rapid and simple procedure for chronic cannulation of the rat jugular vein. J Appl Physiol 36: 391–392

    PubMed  Google Scholar 

  • Ivanetich KM, Goold RD, Sikakana CNT (1990) Explanation of the non-hyperbolic kinetics of the glutathione S-transferase by the simplest steady-state random sequential Bi Bi mechanism. Biochem Pharmacol 39: 1999–2004

    PubMed  Google Scholar 

  • Jersey GC, Balmer MF, Quast JF, Park CN, Schuetz DJ, Beyer JE, Olson KJ, McCollister SB, Rampy LW (1978) Two year chronic inhalation toxicity and carcinogenicity study on monomeric styrene in rats. Manufacturing Chemists Association, MCA No. S74 1.1-Tox-INH, Dow Chemical Co., Midland, MI, USA

    Google Scholar 

  • Johnson MK (1966) Studies on glutathione S-alkyltransferase of the rat. Biochem J 93: 44–55

    Google Scholar 

  • Kapitulnik J, Levin W, Lu AYH, Morecki R, Dansette PM, Jerina DM, Conney AH (1977) Hydration of arene and alkene oxides by epoxide hydrase in human liver microsomes. Clin Pharmac Ther 21: 158–165

    Google Scholar 

  • Knodell RG, Hall SD, Winkingon GR, Guengerich FP (1987) Hepatic metabolism of tolbutamide: In vivo characterization of the form of cytochrome P-450 involved in methyl hydroxylation and relationship to in vivo disposition. J Pharmacol Exp Ther 241: 1112–1119

    PubMed  Google Scholar 

  • Langvardt PW, Nolan RJ (1991) Determination of styrene-7,8-oxide in whole rat blood by gas chromatography-mass spectrometry. J Chromatogr 567: 93–103

    PubMed  Google Scholar 

  • Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193: 265–275

    PubMed  Google Scholar 

  • Miller RR, Letts RL, Potts WJ, McKenna MJ (1980) Improved methodology for generating controlled test atmospheres. Am Ind Hyg Assoc J 4: 844–846

    Google Scholar 

  • Oesch F (1973) Mammalian epoxide hydrases: inducible enzymes catalysing the inactivation of carcinogenic and cytotoxic metabolites derived from aromatic and olefinic compounds. Xenobiotica 3: 305–340

    PubMed  Google Scholar 

  • Oesch F, Daly J (1971) Solubilization, purification, and properties of hepatic epoxide hydrase. Biochim Biophys Acta 227: 692–697

    PubMed  Google Scholar 

  • Oesch F, Jerina DM, Daly J (1971) A radiometric assay for hepatic epoxide hydrase activity with [7-3H] styrene oxide. Biochim Biophys Acta 227: 685

    PubMed  Google Scholar 

  • Pacifici GM, Boobis AR, Brodie MJ, Davies DS (1979) A rapid sensitive assay for glutathione S-transferase activity: species differences in the activity of the hepatic enzyme. Biochem Soc Trans 7: 1060–1061

    PubMed  Google Scholar 

  • Pacifici GM, Boobis AR, Brodie MJ, McManus ME, Davies DS (1981) Tissue and species differences in enzymes of epoxide metabolism. Xenobiotica 11: 73–79

    PubMed  Google Scholar 

  • Pacifici GM, Warholm M, Guthenberg C, Mannervik B, Rane A (1987) Detoxification of styrene oxide by human liver glutathione tansferase. Human Toxicol 6: 483–489

    Google Scholar 

  • Pacifici GM, Franchi M, Bencini C, Repetti F, Di Lascio N, Muraro GB (1988) Tissue distribution of drug-metabolizing enzymes in humans. Xenobiotica 18: 849–956

    PubMed  Google Scholar 

  • Pantarotto CM, Salmona M, Szczawinska K, Bidoli F (1980) Gas Chromatographic — mass spectrometric studies on styrene toxicity. ISS Anal Tech Environ Chem 3: 245–279

    Google Scholar 

  • Parkki MG, Marniemi J, Vainio H (1976) Action of styrene and its metabolites styrene oxide and styrene glycol on activities of xenobiotic biotransformation enzymes in rat liver in vivo. Toxicol Appl Pharmacol 38: 59–70

    PubMed  Google Scholar 

  • Ramsey JC, Andersen ME (1984) A physiological based description of the inhalation pharmacokinetics of styrene in rats and humans. Toxicol Appl Pharmacol 73: 159–175

    PubMed  Google Scholar 

  • Reitz RH, Mendrala AL, Guengerich FP (1989) In vitro metabolism of methylene chloride in human and animal tissues: use in physiologically based pharmacokinetic models. Toxicol Appl Pharmacol 97: 230–246

    PubMed  Google Scholar 

  • Ryan AJ, Bend JR (1977) The metabolism of styrene oxide in the isolated perfused rat liver. Drug Metab Disp 5: 363–367

    Google Scholar 

  • Salmona M, Pachecka J, Cantoni L, Belvedere G, Mussini E, Garattini S (1976) Microsomal styrene mono-oxygenase and styrene epoxide hydrase in rats. Xenobiotica 6: 585–591

    PubMed  Google Scholar 

  • Van Anda J, Smith BR, Fouts JR, Bend JR (1979) Concentration-dependent metabolism and toxicity of [14C] styrene oxide in the isolated perfused rat liver. J Pharmacol Exp Ther 211: 207–212

    PubMed  Google Scholar 

  • Von Bahr C, Groth CG, Jansson H, Lundgren G, Lind M, Glaumann H (1980) Drug metabolism in human liver in vitro: establishment of a human liver bank. Clin Pharmacol Ther 27: 711–725

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Toxicology Research Laboratory, Health and Environmental Sciences, The Dow Chemical Company, 1803 Building, 48674, Midland, MI, USA

    Alan L. Mendrala, Patrick W. Langvardt, Kenneth D. Nitschke, John F. Quast & Richard J. Nolan

Authors
  1. Alan L. Mendrala
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Patrick W. Langvardt
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Kenneth D. Nitschke
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. John F. Quast
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Richard J. Nolan
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mendrala, A.L., Langvardt, P.W., Nitschke, K.D. et al. In vitro kinetics of styrene and styrene oxide metabolism in rat, mouse, and human. Arch Toxicol 67, 18–27 (1993). https://doi.org/10.1007/BF02072030

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02072030

Key words

Search

Navigation